Riskpilot← Back to searchSign inGet full accessPharmacosmos Facilities ApS
APSActiveCVR 42388084Rørvangsvej 30Rental and operating of own or leased real estate · NACE 6820Est. 2021— employees
Revenue 2025
DKK 21,2M
+2% vs 2024
EBITDA margin
98.7%
+15% vs 2024
Equity ratio
7.1%
Financial strength
Net profit 2025
DKK 9,5M
+10% vs 2024
| Revenue | DKK 21,2M | +2% |
| EBITDA | DKK 20,9M | +15% |
| Net profit | DKK 9,5M | +10% |
| Total assets | DKK 311,7M | -16% |
| Equity | DKK 22M | -58% |
| Employees | — | — |
Legal name
Pharmacosmos Facilities ApS
CVR number
42388084
Legal form
Anpartsselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
12. maj 2021
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør.
Company purpose
Selskabets formål er at eje og udleje fast ejendom og produktionsanlæg samt at udøve anden virksomhed,
der står i forbindelse hermed.
Address
Rørvangsvej 30
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 17.477 | 17.303 | 18.420 | 20.702 | 21.206 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 17.438 | 17.245 | 18.378 | 18.159 | 20.921 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 17.438 | 17.245 | 18.378 | 18.159 | 20.921 |
| Net financials | -915 | -903 | -6.861 | -6.444 | -8.685 |
| Profit before tax | 16.523 | 16.342 | 11.517 | 11.715 | 12.236 |
| Tax | 3.573 | 3.595 | 3.452 | 3.069 | 2.692 |
| Net profit | 12.950 | 12.747 | 8.065 | 8.646 | 9.544 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 262.328 | 250.187 | 325.456 | 369.160 | 311.668 |
| Equity | 22.990 | 35.737 | 43.802 | 52.448 | 21.992 |
| Long-term debt | 187.276 | 170.199 | 250.935 | 241.811 | 265.964 |
| Short-term debt | 35.535 | 27.490 | 13.902 | 57.239 | 23.712 |
| Total debt | 222.811 | 197.689 | 264.837 | 299.050 | 289.676 |
EBITDA margin
98.7%
This company
15.8%
Market median
+525% vs market
20212025
Equity ratio
7.1%
This company
38.2%
Market median
-81% vs market
20212025
Return on equity
43.4%
This company
18.4%
Market median
+136% vs market
20212025
Net profit margin
45.0%
This company
8.1%
Market median
+456% vs market
20212025
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20212025
Debt / equity
13.17×
This company
0.62×
Market median
-2024% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HP Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
RG Management | Management | 2021 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PHARMACOSMOS HOLDING A/S | Company | 100.0% | 100.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medicosmos Holding A/SMedicosmos A/SPHARMACOSMOS HOLDING A/S
Pharmacosmos Facilities ApS (this company)Board members of Pharmacosmos Facilities ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Parker | Chief Executive Officer | 0 companies |
| Robert Guglielmetti | Management | 0 companies |